| Using a Semiautomated Procedure (CleanADHdata.R Script) to Clean Electronic Adherence Monitoring Data: Tutorial | JMIR formative research |  | | 2024 | 57 | 146 |
|
| The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study | Frontiers in pharmacology | | | 2024 | 75 | 97 |
|
| Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study | Cancers | | | 2024 | 77 | 348 |
|
| A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial | PloS one | | | 2024 | 106 | 46 |
|
| Néphropathie diabétique : soutenir l’adhésion médicamenteuse de façon interprofessionnelle | Revue médicale suisse | | | 2023 | 94 | 34 |
|
| An interprofessional intervention to support adherence to complex and polypharmacy treatments in patients with solid cancer and patients with diabetic kidney disease | | | | 2023 | 473 | 266 |
|
| Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study | Cancers | | | 2023 | 177 | 106 |
|
| Swiss priority setting on implementing medication adherence interventions as part of the European ENABLE COST action | International journal of public health | | | 2022 | 157 | 133 |
|
| Interventions to Support Adherence to Oral Anticancer Therapies: Research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland | Supportive care in cancer | | | 2022 | 298 | 432 |
|
| Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study | Diabetology & metabolic syndrome | | | 2022 | 126 | 205 |
|
| Medication adherence evaluated through electronic monitors during the 2020 COVID-19 pandemic lockdown in Switzerland: a longitudinal analysis | Patient preference and adherence | | | 2022 | 159 | 130 |
|
| Population pharmacokinetics of palbociclib and its correlation with clinical efficacy and safety in patients with advanced breast cancer | Pharmaceutics | | | 2022 | 134 | 228 |
|
| Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS) | JMIR Research Protocols | | | 2021 | 459 | 328 |
|
| Optimizing oral targeted anticancer therapies study for patients with solid cancer: protocol for a randomized controlled medication adherence program along with systematic collection and modeling of pharmacokinetic and pharmacodynamic data | JMIR research protocols | | | 2021 | 238 | 345 |
|
| Adhésion thérapeutique et collaboration médecin-pharmacien. L’exemple du patient avec néphropathie diabétique | Revue médicale suisse | | | 2020 | 297 | 227 |
|
